https://www.urotoday.com/conference-highlights/suo-2022/suo-2022-prostate-cancer/141072-suo-2022-use-of-exogenous-testosterone-in-the-setting-of-screening-active-surveillance-and-after-treatment-of-localized-disease.html
(UroToday.com) At the 2022 Prostate Cancer Session of the Annual Meeting...
In this video, PCRI's Alex asks Mark Scholz, MD, questions from our YouTube comments about radiation and hormone therapy for prostate cancer. Dr. Scholz is a medical oncologist specializing exclusively in prostate cancer.
0:07 What is the risk of developing secondary cancers after radiation...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.